Chargement en cours...
Brexanolone as adjunctive therapy in super‐refractory status epilepticus
OBJECTIVE: Super‐refractory status epilepticus (SRSE) is a life‐threatening form of status epilepticus that continues or recurs despite 24 hours or more of anesthetic treatment. We conducted a multicenter, phase 1/2 study in SRSE patients to evaluate the safety and tolerability of brexanolone (USAN;...
Enregistré dans:
| Publié dans: | Ann Neurol |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5639357/ https://ncbi.nlm.nih.gov/pubmed/28779545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25008 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|